Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

 

Ventricular Assist Devices Market


Ventricular assist devices are external devices that are attached to a patient's body and help to pump blood throughout the body. It is primarily used in the treatment of heart failure patients. It is a high-end device that mimics the function of the heart. Heart failure is a condition in which the heart muscles weaken and are unable to pump enough blood to the body. Ventricular Assist Devices Market is caused by a variety of conditions, including heart attacks, high blood pressure, defective heart valves, irregular heart rhythms, diabetes, and chronic kidney and lung diseases. Medication, implantable heart devices (pacemakers), and heart transplantation are some of the treatment options for heart failure. However, these approaches have limitations that may result in advanced heart failure, increasing the demand for ventricular assist devices.

The prevalence of heart failure is rising due to lifestyle changes and diseases associated with it. According to the Global Health Data Exchange (GHDx) registry, 64.37 million people worldwide will be suffering from heart failure in 2020. The mortality rate from heart failure can be reduced by using effective therapies and devices such as implantable cardiac defibrillators (ICD), cardiac resynchronization therapy (CRT), and Ventricular Assist Devices Market, among others. VADs are used as a definitive treatment or as a bridge to transplant in patients with advanced heart failure.

Ventricular Assist Devices Market is frequently used in the treatment of patients at risk of cardiac complications. As a result, there is an increasing demand for these devices to treat the underlying problem of heart failure. According to the Scientific Registry of Transplant Recipients (SRTR), approximately 42% of all heart transplant patients had a ventricular assist device at the time of heart transplant. Companies are focusing on heart failure device R&D due to increased demand.

Key Players

Abiomed, Inc., Abbott Laboratories, Heart Ware International, Inc., Berlin Heart GmbH, Thoratec, Inc., Liva Nova plc, Jarvik Heart, Inc., Medtronic plc, ReliantHeart, Inc., and Calon Cardio-Technology Ltd are among the key players in the ventricular assist devices market.

Comments